Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: A tissue-Doppler imaging study

Journal of Hypertension

Volumn 31, Issue 10, 2013, Pages 2077-2084

  Catena, Cristiana ^a   Colussi, Gianluca ^a   Fedrizzi, Stefania ^a   Sechi, Leonardo A ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

D dimer; Diastolic heart failure; Echocardiography; Fibrinogen; Prothrombotic state

Indexed keywords

D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIAC IMAGING; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; TISSUE DOPPLER IMAGING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEART FAILURE; HEMOSTASIS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; RISK FACTORS; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 84884393332     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328362d951     Document Type: Article

References (45)

1. Bathia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355:260-269.
2. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, et al. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24:320-328.
3. Molgevan R, Sogaard P, Pedersen SA, Olsen NT, Marott JL, Schnohr P, et al. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 2009; 119:2679-2686.
4. Wood P, Piran S, Liu PP. Diastolic heart failure: progress, treatment challenges, and prevention. Can J Cardiol 2011; 27:302-310.
5. Ommen SER, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000; 102:1788-1794.
6. Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction. A comparative Doppler-conductance catheterization study. Circulation 2007; 116:637-647.
7. Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005; 40:1215-1220.
8. Lowe GD. Fibrin D-dimer and cardiovascular risk. Semin Vasc Med 2005; 5:387-398.
9. Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S. Relationships of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 2000; 36:978-985.
10. Catena C, Colussi GL, Valeri M, Sechi LA. Association of plasma aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels. Am J Hypertens 2013; 26:111-117.
11. Lip GY, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, thrombogenesis, and hemoreology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997; 80:1566-1571.
12. Palmieri V, Celentano A, Roman MJ, de Simone G, Lewis MR, Best L, et al. Fibrinogen and preclinical echocardiographic target organ damage: the Strong Heart Study. Hypertension 2001; 38:1068-1074.
13. Catena C, Zingaro L, Casaccio D, Sechi LA. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 2000; 109:556-561.
14. Mancia G, De Backer G, Dominczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1751-1762.
15. Catena C, Novello M, Dotto L, De Marchi S, Sechi LA. Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage. J Hypertens 2003; 21:281-288.
16. Sechi LA, Zingaro L, Catena C, De Marchi S. Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events. Thromb Haemost 2000; 84:565-570.
17. Sechi LA, Novello M, Colussi GL, Di Fabio A, Chiuch A, Nadalini E, et al. Relationship of plasma renin with a prothombotic state in hypertension: relevance for organ damage. Am J Hypertens 2008; 21:1347-1353.
18. Rossi E, Lombardi A, Preda L. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 1988; 52:453-468.
19. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, et al. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31:767-778.
20. Peltzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 12 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65:153-199.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for Chamber Quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
23. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi W. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force for the nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15:167-184.
24. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular function by echocardiography. J Am Soc Echocardiogr 2009; 22:107-133.
25. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assessment of mitral annulus velocities by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30:474-480.
26. Garcia MJ, Thomas JD, Klein AN. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32:865-875.
27. Henein M, Linqvist P, Francis D, Morner S, Waldenstrom A, Kazzam E. Tissue Doppler analysis of age-dependence in diastolic ventricular behavior and filling: a cross-sectional study of healthy hearts (the Umea General Population Heart Study). Eur Heart J 2002; 23:162-171.
28. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayasta D, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomized trial. Lancet 2007; 369:2079-2087.
29. Lip GY, Li-Saw-Hee FL. Does hypertension confer a hypercoagulable state? J Hypertens 1998; 16:913-916.
30. Blann AD, Lip GY, Islim IF, Beevers DG. Evidence of platelet activation in hypertension. J Hum Hypertens 1997; 11:607-609.
31. Poli KA, Tofler GH, Larson MG, Evans JC, Sutherland PA, Lipinska I, et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation 2000; 101:264-269.
32. Lip GY, Blann AD. Does hypertension confer a hypercoagulable state? The Vircow's triad revisited. Circulation 2000; 101:218-220.
33. Catena C, Novello M, Lapenna R, Baroselli S, Colussi GL, Nadalini E, et al. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens 2005; 23:1617-1631.
34. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherlan P, Lipinska I, et al. Association of fibrinogen with cardiovascular disease in the Framingham Offspring Population. Circulation 2000; 102:1634-1638.
35. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294:1799-1809.
36. Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 2008; 51:1775-1783.
37. Engstrom G, Hedblad B, Tyden P, Lindgarde F. Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study. Atherosclerosis 2009; 202:617-622.
38. Yan RT, Fernandes V, Yan AT, Cushman M, Redheuil A, Tracy R, et al. Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2010; 160:479-486.
39. Palmieri V, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN, et al. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the Strong Heart Study. Diabetes Care 2003; 26:2764-2769.
40. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, et al. Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest 2003; 33:561-566.
41. Lip GY, Lowe GDO, Metcalfe MJ, Rumley A, Dunn FG. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. Int J Cardiol 1995; 50:31-42.
42. Lee KW, Blann AD, Lip GY. Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation. Am Heart J 2005; 1507:756-766.
43. Henareh L, Jederfords C, Jogestrand T, Brodin LA, Agewall S. Intimamedia thickness of common carotid and brachial arteries and prothrombin fragment 12 are associated with left ventricular diastolic dysfunction in patients with myocardial infarction. Echocardiography 2010; 27:651-658.
44. Lominadze D, Dean WL, Tyagi SC, Roberts AM. Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol 2010; 198:1-13.
45. Szaba FM, Smiley ST. Roles of thrombin and fibrin(ogen) in cytokine/ chemokine production and macrophage adhesion in vivo. Blood 2002; 99:1053-1059.